Para quem é direcionado este curso: The target audience consists of health care practitioners in the fields of gastroenterology, medical oncology, pathology, psychiatry, pulmonary medicine, radiation oncology, radiology, and thoracic surgery. The course should be of interest to practicing physicians, doctors in training (e.g. senior medical students, residents, fellows), and other clinicians, including nurse practitioners, physician assistants, etc. The core curriculum will give learners a base of knowledge and understanding to draw and build upon in their day to day clinical activities in thoracic cancer care.


Desenvolvido por:   Universidade de Michigan

NívelAdvanced
Compromisso7 weeks of study, 2-4 hours/week
Idioma
English
Como ser aprovadoSeja aprovado em todas as tarefas para concluir o curso.
Classificação do usuário
4.9 stars
Average User Rating 4.9Veja o que os aprendizes disseram
Programa

Perguntas frequentes
Como funciona
Trabalho
Trabalho

Cada curso é como um livro didático interativo, com vídeos pré-gravados, testes e projetos.

Ajuda dos seus colegas
Ajuda dos seus colegas

Conecte-se com milhares de outros aprendizes, debata ideias, discuta sobre os materiais do curso e obtenha ajuda para dominar conceitos.

Certificados
Certificados

Obtenha reconhecimento oficial pelo seu trabalho e compartilhe seu sucesso com amigos, colegas e empregadores.

Desenvolvedores
Universidade de Michigan
The mission of the University of Michigan is to serve the people of Michigan and the world through preeminence in creating, communicating, preserving and applying knowledge, art, and academic values, and in developing leaders and citizens who will challenge the present and enrich the future.
Classificações e avaliações
Avaliado em 4.9 de 5 decorrente de 33 avaliações

Excellent course .

A very comprehensive overview of lung and esophageal cancer, from risk factors, to diagnosis, staging, surgery, palliative care, psychological support and pain management. I thoroughly enjoyed participating in this excellently presented course.

As a pediatric oncologist, I have not had to deal with either lung or esophageal cancers.

The use of endoscopic analysis for determining lymph node involvement was quite an eye-opener.

Likewise, the immunologic histochemical variation was a valuable learning experience as were the

pathologic descriptions of adenoca variants.

The only possible criticism might be the thoracic surgeons use of acronyms without explanation, but

this was minor.

Kudos to the team

Gratefully Gerald Vladimer MD

Very important, helpful and very very well done. Thanks a lot



Compartilhar